Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNP | P00491 | 4/20 | 0.79 |
| ▸ | MAPT | P10636 | 2/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.65 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | TLR7 | Q9NYK1 | 2/20 | 0.55 |
| ▸ | BLM | P54132 | 1/20 | 0.55 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.55 |
| ▸ | NADK | O95544 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.45 |
| ▸ | HSPA8 | P11142 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12150662 | 1.00 | PNP (0.79) | PNPMAPTCYP3A4MEN1KMT2A | |
| SCHEMBL56018 | 1.00 | PNP (0.79) | PNPMAPTCYP3A4MEN1KMT2A | |
| SCHEMBL14941501 | 1.00 | PNP (0.79) | PNPMAPTCYP3A4MEN1KMT2A | |
| SCHEMBL12030980 | 1.00 | PNP (0.79) | PNPMAPTCYP3A4MEN1KMT2A | |
| SCHEMBL10117789 | 1.00 | PNP (0.79) | PNPMAPTCYP3A4MEN1KMT2A | |
| SCHEMBL23202308 | 1.00 | PNP (0.79) | PNPMAPTCYP3A4MEN1KMT2A | |
| SCHEMBL12746818 | 1.00 | PNP (0.79) | PNPMAPTCYP3A4MEN1KMT2A | |
| SCHEMBL2774442 | 1.00 | PNP (0.79) | PNPMAPTCYP3A4MEN1KMT2A | |
| Water SCHEMBL5501671 | 0.99 | PNP (0.78) | PNPMAPTCYP3A4MEN1KMT2A | |
| Water SCHEMBL5501677 | 0.99 | PNP (0.78) | PNPMAPTCYP3A4MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4277 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4598504-A2 | MICROPARTICLE AND IMPLANT FORMULATIONS FOR CGMP ANALOG THERAPY | Mireca Medicines GmbH (DE) | 2025-08-13 | — | — | EP | claimed |
| CN-120077132-A | Modulation of SUV39H1 expression by RNA | 姆内莫治疗公司 | 2025-05-30 | — | — | CN | claimed |
| US-20250115916-A1 | MODULATION OF SUV39H1 EXPRESSION BY RNAS | MNEMO THERAPEUTICS (FR) | 2025-04-10 | — | — | US | claimed |
| EP-4466356-A1 | MODULATION OF SUV39H1 EXPRESSION BY RNAS | Mnemo Therapeutics (FR) | 2024-11-27 | — | — | EP | claimed |
| WO-2024074585-A2 | MICROPARTICLE AND IMPLANT FORMULATIONS FOR cGMP ANALOG THERAPY | MIRECA MEDICINES GMBH (DE) | 2024-04-11 | — | — | WO | claimed |
| EP-3353298-B1 | ALLELE SELECTIVE GENE EDITING AND USES THEREOF | ARCTURUS THERAPEUTICS INC (US) | 2023-09-13 | — | — | EP | claimed |
| WO-2023139269-A1 | MODULATION OF SUV39H1 EXPRESSION BY RNAS | MNEMO THERAPEUTICS (FR) | 2023-07-27 | — | — | WO | claimed |
| CN-112641951-B | Bioactive supermolecule chiral hydrogel and preparation method and application thereof | 河南工业大学 | 2023-03-28 | — | — | CN | claimed |
| CN-111804246-B | Supermolecule eutectic solvent gel and preparation method and application thereof | 河南工业大学 | 2022-06-14 | — | — | CN | claimed |
| CN-108350454-B | Allele-selective gene editing and uses thereof | 阿克丘勒斯治疗公司 | 2022-05-10 | — | — | CN | claimed |
| EP-1499187-A2 | IMMUNOSTIMULATORY G,U-CONTAINING OLIGORIBONUCLEOTIDES | Coley Pharmaceutical GmbH (DE) | 2005-01-26 | — | — | EP | claimed |
| EP-0914110-B1 | METHOD OF MODULATING MICROCIRCULATION | NOVARTIS AG (CH) | 2005-01-26 | — | — | EP | claimed |
| US-20040110717-A1 | Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase | MERCK SHARP & DOHME LLC | 2004-06-10 | — | — | US | claimed |
| US-20040110718-A1 | Anti-HCV nucleoside derivatives | DEVOS RENE (GB) | 2004-06-10 | — | — | US | claimed |
| US-20030232074-A1 | For stimulating immune activation; for screening immunostimulatory compounds | COLEY PHARMACEUTICAL GMBH (DE) | 2003-12-18 | — | — | US | claimed |
| WO-2003086280-A2 | IMMUNOSTIMULATORY G,U-CONTAINING OLIGORIBONUCLEOTIDES | COLEY PHARMACEUTICAL GMBH (DE) | 2003-10-23 | — | — | WO | claimed |
| US-20030008841-A1 | Anti-HCV nucleoside derivatives | F. HOFFMAN-LA ROCHE, A SWISS COMPANY (CH) | 2003-01-09 | — | — | US | claimed |
| WO-2002057425-A2 | NUCLEOSIDE DERIVATIVES AS INHIBITORS OF RNA-DEPENDENT RNA VIRAL POLYMERASE | MERCK & CO., INC. (US) | 2002-07-25 | — | — | WO | claimed |
| US-4746651-A | ANTIBIOTIC AND ALDOGYCOSIDYL-GUANINE OR ISOXANTHOPTERIN IMMUNE RESPONSE-ENHANCING AGENT | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1988-05-24 | — | — | US | claimed |
| US-4539205-A | Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1985-09-03 | — | — | US | claimed |